乳腺癌组织中BRCA1、ALDH1及nm23的表达及临床意义
DOI:
作者:
作者单位:

作者简介:

通讯作者:

基金项目:

Breast cancer susceptibility gene 1; Acetaldehyde dehydrogenase 1; nm23; Breast cancer


Expression and clinical significance of BRCA1, ALDH1 and nm23 on breast cancer
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    【摘要】 目的 探讨乳腺癌组织中BRCA1、ALDH1及nm23的表达及临床意义。方法 纳入2002~2008年在宁夏医科大学总医院肿瘤医院肿瘤外科手术治疗的乳腺癌患者836例为研究对象,随访确定术后5年内因乳腺癌死亡患者为死亡组(n=49),无瘤生存乳腺癌患者作为对照组(n=49)。应用免疫组织化学染色法检测BRCA1、ALDH1、nm23在乳腺癌组织中的表达,采用Spearman’s等级相关分析BRCA1、ALDH1、nm23的相关性。结果 死亡组BRCA1和nm23表达低于对照组(P<005),ALDH1表达高于对照组(P<005);乳腺癌组织中ALDH1与BRCA1、nm23呈负相关(P<005),BRCA1与nm23呈正相关(P<005)。结论 BRCA1、ALDH1、nm23在乳腺癌组织中存在差异表达,其共同检测有望成为预测乳腺癌预后及指导治疗的生物学指标。

    Abstract:

    【Abstract】 Objective To explore the expression and clinical significance of BRCA1, ALDH1 and nm23 on breast cancer. Methods There are 836 patients with operable breast cancer diagnosed in Oncological Surgery of Affiliated Hospital of Ningxia Medical University from 2002 to 2008 were recruited. The patients were divided into death group and control group after following up for 5 years. Protein expressions of BRCA1, ALDH1 and nm23 in cancer tissue were assayed by immunehistochemical staining. Spearman’s means was used to analyze the correlation of BRAC1, ALDH1 and nm23. Results Protein expression of BRCA1 and nm23 were lower in death group than control group. Expression of ALDH1 was increased in death group compared to the control group. Expression of ALDH1 in cancer tissue was negative correlated to BRCA1 and nm23, and expression of BRCA1 was positive to nm23. Conclusion Joint detection of BRCA1, ALDH1 and nm23 might be a biological marker for forecasting prognosis and directing therapy of breast cancer.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2019-07-26
您是第位访问者
网站版权所有:《西部医学》编辑部     蜀ICP备18038379号-4
地址:四川省成都市武侯区小天竺街75号财富国际18F-1号    邮政编码:610041
电话:028-85570072/85588403 本网站支持 IPv6    E-mail:xbyxqk@163.com
技术支持:北京勤云科技发展有限公司